Jim Simons's position in Genmab - ADR is currently worth $41.4 Million. That's 0.06% of their equity portfolio (355th largest holding). The first Genmab - ADR trade was made in Q1 2020. Since then Jim Simons bought shares eight more times and sold shares on seven occasions. The investor's estimated purchase price is $49.2 Million, resulting in a loss of 16%.